1-2 of 2
Steven Kornblau, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcome with the Hyper-CVAD and Imatinib Mesylate Regimen in Philadelphia (Ph) Positive Acute Lymphocytic Leukemia (ALL).

Deborah A. Thomas, MD, Stefan Faderl, MD, Jorge Cortes, MD, Susan O’Brien, MD, Francis Giles, MD, Guillermo Garcia-Manero, MD, Steven Kornblau, MD, PhD, Michael Andreeff, MD, PhD, Miloslav Beran, MD, PhD, Srdan Verstovsek, MD, PhD, Sherry Pierce, RN, Laurie Letvak, MD, August Salvado, MD, Richard Champlin, MD, Hagop Kantarjian, MD
Journal: Blood
Blood (2005) 106 (11): 1830.
https://doi.org/10.1182/blood.V106.11.1830.1830
Published: 2005
Journal Articles

Update of the Modified Hyper-CVAD Regimen with or without Rituximab in Newly Diagnosed Adult Acute Lymphocytic Leukemia (ALL).

Deborah A. Thomas, MD, Jorge Cortes, MD, Susan O’Brien, MD, Stefan Faderl, MD, Farhad Ravandi, MD, Gullermo Garcia-Manero, MD, Francis Giles, MD, Miloslav Beran, MD, PhD, Charles Koller, MD, William Wierda, MD, PhD, Srdan Verstovsek, MD, PhD, Alessandra Ferrajoli, MD, PhD, Steven Kornblau, MD, PhD, Michael Keating, MD, Michael Andreeff, MD, PhD, Hagop Kantarjian, MD
Journal: Blood
Blood (2005) 106 (11): 1831.
https://doi.org/10.1182/blood.V106.11.1831.1831
Published: 2005